Tackling monoclonal antibody drug discovery

22 Nov 2022

In this application eBook, discover how to overcome workflow challenges associated with monoclonal antibody (mAb) drug discovery. Plus, explore high-throughput solutions to help you meet increasing time and cost pressures.

CellXpert® C170 CO2 incubator

Eppendorf

2019 Model: Homogenous temperature verified at 27 points | Fast atmosphere recovery | Fan-less, seamless chamber | Changeable door handle position | Intuitive interface | Up to 25% more space | Saves money | No internal replacement parts

(4)

Links

Tags

Tackling monoclonal antibody drug discovery